Cantley Lab

You are here

News

April 3, 2017

A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers.

Read full story
February 6, 2017

Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D.

Read full story
January 27, 2017

Dr. Cantley was recently elected as Chairman of the Board of Trustees of the Hope Funds for Cancer Research, a charity dedicated to advancing innovative research for the most difficult-to-treat cancers.

Read full story
January 18, 2017

Dr. Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism.

Read full story
January 9, 2017

Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved.

Read full story
November 9, 2016

Dr. Cantley was among seven selected for the third round of the Daedalus Fund for Innovation awards. 

Read full story
November 8, 2016

The metabolic state of patients influences their cancer risk, progression and response to treatment.

Read the full story
November 5, 2016

A new study echoes the findings of the Cantley Lab regarding the potential of Vitamin C as a cancer-killing therapy. 

Read the full story
September 1, 2016

Cornell University and Weill Cornell will establish a new multi-institutional translational research Center on the Physics of Cancer Metabolism, thanks to a $9.3m National Cancer Institute grant

Read the full story
August 10, 2016

Dr. Cantley and former postdoc Costas Lyssiotis were involved in a study about pancreatic cancer metabolism.

Read the full story

Weill Cornell Medicine
Cantley Lab
Weill Cornell Medical College Meyer Cancer Center
Belfer Research Building
413 E 69th St.
Room 1362, Box 50
New York, NY 10021 Phone: (646) 962-6297